A phase 3 clinical trial of treatment for idiopathic pulmonary fibrosis, sponsored by Weill Cornell Medicine, could pave the way for cheaper studies that are easier to conduct.
A team led by researchers at Weill Cornell Medicine and their colleagues has developed a machine learning technique for identifying genetic mutations that trigger the disease.
Excess sugar in the blood, the central feature of diabetes, can react with immune proteins to cause myriad changes in the immune system, including inflammatory changes that promote atherosclerosis, according to a new study.
The annual event showcased the wide range of cancer research taking place across Cornell colleges and campuses, and allowed faculty and students to identify potential areas for collaboration.
When Kaavian Shariati ’20 learned he had Type 1 diabetes shortly before arriving at Cornell, he was shocked not only by his new responsibilities – monitoring his insulin levels day and night – but by the state of diabetes research.
Cornell’s nearly 50-year-old Empathy, Assistance and Referral Service (EARS) will begin offering a new model of support this fall, including peer mentoring, training and outreach.
Dr. Geraldine McGinty, an esteemed clinical operations strategist, administrator and radiologist, has been appointed senior associate dean for clinical affairs at Weill Cornell Medicine, effective Sept. 1.
Nutrition educators from across New York state joined Cooperative Extension staff and university faculty June 17-18 for a celebration of the 50th anniversary of the Expanded Food and Nutrition Education Program.